Genes & Cancer

Directions Website

Genes & Cancer Publishes original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology

Having served as the founding editor of Oncogene from 1987 to 2008 and establishing Oncogene as one of the leading cancer journals, Dr. E. Premkumar Reddy launched the journal entitled Genes & Cancer in 2010 which publishes original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology. Its Editorial Board consists of outstanding scientists who are well known for their contributions in the fields of oncogenes/oncoproteins, signal transduction, cancer therapy and other fields of biology and medicine. One of the important goals of the Editorial Office is to shape this journal into a high impact journal. All papers appear in PMC and PubMed. Based on our calculation, Genes & Cancer will soon become a very high impact journal. Genes & Cancer is a member of the Committee on Publication Ethics (COPE) and other international committees.

👀 Watch and subscribe to the Genes & Cancer   channel for author   and   shorts.Our channel ⬇️ https://www.youtube.com/ ...
10/15/2026

👀 Watch and subscribe to the Genes & Cancer channel for author and shorts.

Our channel ⬇️
https://www.youtube.com/

Genes and Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes. Visit https://www.genesandcancer.com/

 : "Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines"DOI ⬇️ https://doi.org...
10/15/2026

: "Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.229

In recent years, immunotherapy has finally found its place in the anti-cancer therapeutic arsenal, even becoming standard of care as first line treatment for metastatic forms. The clinical benefit pro

For  : We aim to amplify your work's visibility. Our in-house digital team crafts & circulates original   inspired by   ...
10/14/2026

For : We aim to amplify your work's visibility.

Our in-house digital team crafts & circulates original inspired by published in Genes & Cancer.

Discover more about our FREE promotion services ⬇️ https://www.genesandcancer.com/editorial-policies/ -publication-promotion

10/14/2026

: "Severe herpesvirus infection beats adult T-cell leukemia/lymphoma"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.228

© 2023 Jo. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 : "Dialyl-sulfide with trans-chalcone prevent breast cancer prohibiting SULT1E1 malregulations and oxidant-stress induc...
10/13/2026

: "Dialyl-sulfide with trans-chalcone prevent breast cancer prohibiting SULT1E1 malregulations and oxidant-stress induced HIF1a-MMPs induction"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.237

Background: In some breast cancers, altered estrogen-sulfotransferase (SULT1E1) and its inactivation by oxidative-stress modifies E2 levels. Parallelly, hypoxia-inducible tissue-damaging factors (HIF1

10/12/2026

Submit a paper online with Genes & Cancer ⬇️

🔗 https://genesandcancer.msubmit.net/cgi-bin/main.plex

eJournalPress is mission critical software providing online submission, review and tracking of manuscripts via the Internet. It was designed from the ground up to provide rock solid security, reliability and ease of use.

 : "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modula...
10/12/2026

: "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4"

DOI ⬇️
https://bit.ly/4hA2SC2

The MYC gene is a regulatory and proto-oncogenic gene that is overexpressed in the majority of prostate cancers (PCa). Numerous studies have indicated that aberrant expression of microRNAs is involved

Genes & Cancer Publication Ethics and Publication Malpractice Statements: https://www.genesandcancer.com/ethics-statemen...
10/09/2026

Genes & Cancer Publication Ethics and Publication Malpractice Statements: https://www.genesandcancer.com/ethics-statement/

Genes & Cancer is a peer-reviewed, open-access journal covering the genetic and molecular basis of cancer.

Address

6666 East Quaker Str. , Suite 4
Orchard Park, NY
14127

Alerts

Be the first to know and let us send you an email when Genes & Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share